Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader and Company Panel
QIMC Reports Record 23.5% Natural Hydrogen Within the First 300 Metres of Ongoing DDH-26-05 and Observations Consistent with Free Gas at Bennett Hill at 164 Metres
Apex Resources Receives TSX Venture Exchange Acceptance to Grant of Option to Tungsten Reserve Corp. to Explore and Mine Tungsten Zones in the Jersey-Emerald Project in BC
